The in3 project is funded by the EU’s Marie Sklodowska-Curie Action – Innovative Training Network (MSCA-ITN for short) that aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial (NM) safety assessment. Here are our dedicated, motivated, dynamic, early stage researchers.
| An integrated interdisciplinary approach to animal-free nanomaterial and chemical safety assessment: Results of the in3 project Chairs: Paul Jennings, NL-Amsterdam & Maxime Culot, FR-Lens | ||
| An introduction to the in3 project Maxime Culot, FR-Lens, Paul Jennings, NL-Amsterdam | ||
| In3 Project: a European initiative to evaluate toxicity of chemicals using iPSCs derived in vitro models: Focus on blood brain barrier models for neurotoxicity assessment Sara Wellens, FR-Lens | ||
| Study the effect of cyclosporin A on functionality of endothelial cells differentiated from iPS cells as in vitro toxicology model system Zahra Mazidi, AT-Vienna | ||
| Evaluation of human induced Pluripotent Stem Cell derived podocyte-like cells for toxicity testing Cormac Murphy, NL-Amsterdam (Jennings presented) | ||
| In vitro distribution kinetics and neurotoxicity of the cardiac drug amiodarone in the iPSC-derived human 3D model BrainSpheres Carolina Nunes, CH-Lausanne | ||
Roger Guillemin identified the molecules in the brain that control the production of hormones in…
In 2007, Sinclair wrote the article “Healthy Hair: What is it?” in which he stated,…
We spoke to John Chave, director-general at trade body Cosmetics Europe, about changing regulations, what’s…